Sueoka E - Search Results

1

Primary cancer prevention by green tea, and tertiary cancer prevention by the combination of green tea catechins and anticancer compounds.

Fujiki H, Sueoka E, Watanabe T, Suganuma M. Fujiki H, et al. Among authors: sueoka e. J Cancer Prev. 2015 Mar;20(1):1-4. doi: 10.15430/JCP.2015.20.1.1. J Cancer Prev. 2015. PMID: 25853098 Free PMC article. Review.

2

Nodularin, a potent inhibitor of protein phosphatases 1 and 2A, is a new environmental carcinogen in male F344 rat liver.

Ohta T, Sueoka E, Iida N, Komori A, Suganuma M, Nishiwaki R, Tatematsu M, Kim SJ, Carmichael WW, Fujiki H. Ohta T, et al. Among authors: sueoka e. Cancer Res. 1994 Dec 15;54(24):6402-6. Cancer Res. 1994. PMID: 7527297

3

Activation of protein kinase C by mycobacterial cord factor, trehalose 6-monomycolate, resulting in tumor necrosis factor-alpha release in mouse lung tissues.

Sueoka E, Nishiwaki S, Okabe S, Iida N, Suganuma M, Yano I, Aoki K, Fujiki H. Sueoka E, et al. Jpn J Cancer Res. 1995 Aug;86(8):749-55. doi: 10.1111/j.1349-7006.1995.tb02464.x. Jpn J Cancer Res. 1995. PMID: 7559098 Free PMC article.

4

Tautomycin: an inhibitor of protein phosphatases 1 and 2A but not a tumor promoter on mouse skin and in rat glandular stomach.

Suganuma M, Okabe S, Sueoka E, Nishiwaki R, Komori A, Uda N, Isono K, Fujiki H. Suganuma M, et al. Among authors: sueoka e. J Cancer Res Clin Oncol. 1995;121(9-10):621-7. doi: 10.1007/BF01197780. J Cancer Res Clin Oncol. 1995. PMID: 7559747

5

Two significant aspects of microcystin-LR: specific binding and liver specificity.

Nishiwaki R, Ohta T, Sueoka E, Suganuma M, Harada K, Watanabe MF, Fujiki H. Nishiwaki R, et al. Among authors: sueoka e. Cancer Lett. 1994 Aug 15;83(1-2):283-9. doi: 10.1016/0304-3835(94)90331-x. Cancer Lett. 1994. PMID: 8062225

6

A new tumor promotion pathway and its inhibitors.

Fujiki H, Suganuma M, Komori A, Yatsunami J, Okabe S, Ohta T, Sueoka E. Fujiki H, et al. Among authors: sueoka e. Cancer Detect Prev. 1994;18(1):1-7. Cancer Detect Prev. 1994. PMID: 8162603 Review.

7

Designing of chimeric DNA/RNA hammerhead ribozymes to be targeted against AML1/MTG8 mRNA.

Kozu T, Sueoka E, Okabe S, Sueoka N, Komori A, Fujiki H. Kozu T, et al. Among authors: sueoka e, sueoka n. J Cancer Res Clin Oncol. 1996;122(4):254-6. doi: 10.1007/BF01209655. J Cancer Res Clin Oncol. 1996. PMID: 8601580

8

A new process of cancer prevention mediated through inhibition of tumor necrosis factor alpha expression.

Suganuma M, Okabe S, Sueoka E, Iida N, Komori A, Kim SJ, Fujiki H. Suganuma M, et al. Among authors: sueoka e. Cancer Res. 1996 Aug 15;56(16):3711-5. Cancer Res. 1996. PMID: 8706012

9

Anti-cancer effects of morphine through inhibition of tumour necrosis factor-alpha release and mRNA expression.

Sueoka N, Sueoka E, Okabe S, Fujiki H. Sueoka N, et al. Among authors: sueoka e. Carcinogenesis. 1996 Nov;17(11):2337-41. doi: 10.1093/carcin/17.11.2337. Carcinogenesis. 1996. PMID: 8968046

10

Japanese green tea as a cancer preventive in humans.

Fujiki H, Suganuma M, Okabe S, Komori A, Sueoka E, Sueoka N, Kozu T, Sakai Y. Fujiki H, et al. Among authors: sueoka e, sueoka n. Nutr Rev. 1996 Nov;54(11 Pt 2):S67-70. doi: 10.1111/j.1753-4887.1996.tb03821.x. Nutr Rev. 1996. PMID: 9110578 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters